Product Description:
BML is Lunching Apalunix 60 mg tablet which is an androgen receptor inhibitor indicated for the treatment of patients with
- Metastatic castration-sensitive prostate cancer
- Non-metastatic castration resistant prostate cancer.
Apalunix works by blocking the effects of androgen (a male reproductive hormone) to stop the growth and spread of cancer cells.
Product Features:
| Product Name | Apalunix |
| Generic Name | Apalutamide INN |
| Formulation | Tablet |
| Available Pack Size | 120’s pot |
| Available Strength | 60 mg |
| Registrations | Available |
| Website | Apalunix.com |
